BioSpace News Archive

Polyphor AG announced the closing of the previously announced exclusive licensing agreement with Fosun Pharma for balixafortide in China.

The system, based on machine learning algorithms for analyzing EEG signals, can predict upcoming seizures up to an hour prior to onset NeuroHelp, a newly founded startup that licensed and is developing the technology, is a portfolio company of Oazis accelerator, formed by the Yazamut360 entrepreneurship center of Ben-Gurion University

Boehringer Ingelheim has acquired an equity stake in New Ruipeng Group (NRP Group) which operates digital and clinical pet services across China

MiNA Therapeutics, the pioneer in RNA activation therapeutics, announced the appointment of Peter Bains as Chief Business Officer, effective September 22, 2020.

Jellagen® Limited, a marine biotechnology business manufacturing high value collagen derived from jellyfish, has entered into a license agreement for an exclusive grant to patent rights with Mayo Clinic for the development in treatment of vocal cord paralysis.

TearClear announces the appointment of industry veteran Robert Bailey to the company’s Board of Directors.

Kurin announced that it is a winner of the Supplier Horizon Award from Premier Inc., a leading healthcare improvement company.

Caris’ collaborative network focused on expanding the application of precision medicine in oncology welcomes New England’s largest medical oncology group

Renowned surgeon, clinician, and researcher to advance work to combine novel immuno-oncology therapies with regional drug delivery to improve outcomes in metastatic liver and pancreatic tumors

REBLOZYL ® is the first and only erythroid maturation agent approved for use in Canada